Showing results (961-970 of 1,398) with videos related to

Sort By:
Pageof 140
Drug Development Research|December 11, 2024
Heme Oxygenase-1 Overexpression Activates the IRF1/DRP1 Signaling Pathway to Promote M2-Type Polarization of Spinal Cord MicrogliaWenping Lin, Ziming Cai, Jinzhu Liang, et al.
Drug Development Research|December 11, 2024
Design and Discovery of New Dual Carbonic Anhydrase IX and VEGFR-2 Inhibitors Based on the Benzenesulfonamide-Bearing 4-Thiazolidinones/2,4-Thiazolidinediones ScaffoldMerve Zengin, Oya Unsal Tan, Suna Sabuncuoglu, et al.
Drug Development Research|January 1, 2025
Adenosine A1 and A3 Receptors: Distinct CardioprotectionBruce T Liang, Douglas Stewart, Kenneth A Jacobson
Drug Development Research|December 11, 2023
Exploring the potential of radiolabeled duramycin as an infection imaging probeAnuj Kumar, Jyotsna Bhatt Mitra, Elina Khatoon, et al.
Drug Development Research|December 6, 2023
Covalent inhibitors: An ambitious approach for the discovery of newer oncotherapeuticsRameshwar S Cheke, Prashant S Kharkar
Drug Development Research|February 13, 2024
Influence of β-catenin signaling on neurogenesis in neuropsychiatric disorders: Anxiety and depressionRana A El-Kadi, Noha F AbdelKader, Hala F Zaki, et al.
Drug Development Research|February 13, 2024
Drug upgrade: A complete methodology from old drug to new chemical entities using Nematic Protein Organization TechniqueJudith Eschbach, Alain Wagner, Corinne Beahr, et al.
Drug Development Research|January 19, 2024
1,3-Dialkylxanthine Derivatives Having High Potency as Antagonists at Human A2B Adenosine ReceptorsKenneth A Jacobson, Ad P IJzerman, Joel Linden
Drug Development Research|January 19, 2024
Recent Developments in Selective Agonists and Antagonists Acting at Purine and Pyrimidine ReceptorsKenneth A Jacobson, Fumio Suzuki
Drug Development Research|January 29, 2024
Purinoceptors in the Central Nervous SystemT V Dunwiddie, M P Abbracchio, N Bischofberger, et al.
Pageof 140